Abstract
The range and gravity of ethical considerations in stem cell research are remarkable and, quite possibly, unprecedented. From the point of securing stem cells for implantation, through the translational and first-in-human process, and then proceeding through clinical trials culminating in product or service line launch, the entire research trajectory is replete with risk, uncertainty, and problems over weighing foreseeable harms against hoped-for benefits. This paper offers an overview of some of the most salient ethical challenges of stem cell research including ones involving moral status, the intersection of research risks and informed consent processes, methodological considerations in early Phase I trials, the temptation to exaggerate the benefits of research discoveries, managing conflicts of interest, and the ethical obligation to conduct various monitoring practices throughout a trial, which could last years. The article will conclude with a glimpse into the future of these technologies wherein the need for ethical scrutiny will likely not diminish.
The original version of this chapter was revised. An erratum to this chapter can be found at DOI 10.1007/978-3-319-59165-0_16
Reprinted from PM&R Journal, Vol. 7 issue 4S, Banja J.D., Ethical considerations in stem cell research on neurological and orthopedic conditions, S66 – S75, 2015 with permission from Elsevier.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AAMC (2008) Protecting patients, preserving integrity, advancing health: accelerating the implementation of COI policies in human subjects research. http://www.research.uky.edu/ospa/info/docs/AAMCFeb2008COIReport.pdf. Accessed 13 Oct 2016
Amariglio N, Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R et al (2009) Donor-driven brain tumor following neural stem cell transplantation in an ataxia telangiectasis patient. PLoS Med 6(2):e1000029
Bahney CS, Miclau T (2012) Therapeutic potential of stem cells in orthopedics. Indian J Orthop 46(1):4–9
Beauchamp T, Childress JF (2013) Principles of biomedical ethics, 7th edn. Oxford University Press, New York, NY, pp 125–127
Bliss T, Guzman R, Daadi M, Steinberg GK (2007) Cell transplantation therapy for stroke. Stroke 38(Pt 2):817–826
Brody H (2007) Hooked: ethics, the medical profession, and the pharmaceutical industry. Rowman & Littlefield Publishers, Lanham, MD
Centeno C, Bashir J (2015) Safety and regulatory issues regarding stem cell therapies: one clinic’s perspective. PM R 7(4):S4–S7
Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W (2010) Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Cur Stem Cell Res Ther 5:81–93
Code of Federal Regulations, 46.404 and 46.405 (2014). Available at http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html. Accessed Oct 6, 2014
Dobkin BH, Curt A, Guest J (2006) Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair 20(1):5–13
Frank SA, Wilson R, Holloway R, Zimmerman C, Peterson DR, Kieburtz K, Kim SY (2008) Ethics of sham surgery: perspectives of patients. Mov Disord 23:63–68
George K (2007) What about the women? Ethical and policy aspects of egg supply for cloning research. Reprod Biomed Online 15(2):127–133
Gilbert F, Harris AR, Kapsa RMI (2012) Efficacy testing as a primary purpose in Phase 1 clinical trials: is it applicable to first in humans bionics and optogenetics trials? AJOB Neurosci 3(2):20–22
Hernigou P, Homma Y, Flouzat-Lachaniette C, Poignard A, Chevallier N, Rouard H (2013) Cancer risk is not increased in patients treatment for orthopaedic diseases with autologous bone marrow cell concentrate. J Bone Joint Surg Am 95:2215–2221
Hess P (2012) Intracranial stem cell-based transplantation: reconsidering the purpose and ethical justification of Phase 1 clinical trials in light of irreversible interventions in the brain. AJOB Neurosci 3(2):3–13
HHS.gov Office for Human Research Protections (2009) Recommendations from the subcommittee for the inclusion of individuals with impaired decision making in research. http://www.hhs.gov/ohrp/sachrp-committee/recommendations/2009-july-15-letter-attachment/index.html. Accessed 13 Oct 2016
Hurst S, Mauron A, Momjian S, Burkhard PR (2015) Ethical criteria for human trials of stem cell-derived dopaminergic neurons in Parkinson’s disease. AJOB Neurosci 6(1):52–60
Hwang NS, Varghese S, Elisseeff J (2008) Derivation of chondrogenically committed cells from human embryonic cells for cartilage tissue regeneration. PLoS One 3:e2498
Hyun I (2010) Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. J Law Med Ethics 38(2):277–285
Hyun I (2014) Embryonic stem cell research. In: Jennings B (ed) Bioethics, 4th edn. Gale Cengage Learning, Farmington Hills, MI, pp 935–942
Kim K, Doi A, Wen B (2010) Epigenetic memory of induced pluripotent stem cells. Nature 467(7313):285–290
Kim SY, Frank S, Holloway R, Zimmerman C, Wilson R, Kieburtz K (2005) Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers. Arch Neurol 62(9):1357–1360
Kimmelman J (2010) Gene transfer and the ethics of first-in-human research. Cambridge University Press, New York, NY
Kimmelman J, Levenstadt A (2005) Elements of style: consent form language and the therapeutic misconception in Phase gene transfer trials. Hum Gene Ther 16(4):502–508
King NM, Henderson GE, Churchill LR, Davis AM, Hull SC, Nelson DK et al (2005) Consent forms and the therapeutic misconception: the example of gene transfer research. IRB 27:1–8
Lakoff G (2008) The political mind: why you can’t understand 21st-century American politics with an 18th-century brain. Viking, New York, NY
Lau D, Oqboqu U, Taylor B, Stafinski T, Menon D, Caulfield T (2008) Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell 3(6):591–594
Lian Q, Lye E, Suan YK, Khia Way Tan E, Salto-Tellez M, Liu TM et al (2007) Derivation of clinical compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells 25:425–436
Lo B, Parham L (2010) Resolving ethical issues in stem cell clinical trials: the example of Parkinson disease. J Law Med Ethics 38(2):257–266
Macklin R (1999) The ethical problems with sham surgery in clinical research. N Engl J Med 341(13):992–996
Magnus D (2010) Translating stem cell research: challenges at the research frontier. J Law Med Ethics 38(2):267–276
Mautner K, Blazuk J (2015) Where do injectable stem cell transplants apply in treatment of muscle, tendon and ligament injuries? PM R 7(4):S33–S40
McMahon DS (2014) Regenerative medicine. In: Jennings B (ed) Bioethics, 4th edn. Cengage Learning Center, Farmington Hills, MI, pp 2693–2698
Mehta S, Myers TG, Lonner JH, Huffman R, Sennett BJ (2007) The ethics of sham surgery in clinical orthopedic research. J Bone Joint Surg Am 89(7):1650–1653
National Institutes of Health (2009) National Institutes of Health guidelines on human stem cell research. http://stemcells.nih.gov/policy/pages/2009guidelines.aspx. Accessed 13 Oct 2016
Pharmaceutical Research and Manufacturers of America (2013) Medicines in development. Biologics 2013 report. http://www.phrma.org/sites/default/files/pdf/biologics2013.pdf. Accessed 13 Oct 2016
Robertson JA (2010) Embryo stem cell research: ten years of controversy. J Law Med Ethics 38(2):191–203
Sargent B (2013) Fifteen cell therapies/stem cell therapies in Phase III clinical trials. Cell Culture Dish http://www.cirm.ca.gov/sites/default/files/files/agenda/Fifteen_Cell_Therapies_PhaseIII_Clinical_Trials.pdf. Accessed 13 Oct 2016
Schmitt A, van Griensven M, Imhoff AB, Buchmann S (2012) Application of stem cells in orthopedics. Stem Cells Int 2012:394962
Schofferman J, Banja J (2008) Conflicts of interest in pain medicine: practice patterns and relationships with industry. Pain 139:494–497
Sepulveda F, Baerge L, Micheo W (2015) The role of physiatry in regenerative medicine: how will physiatry change the world of regenerative medicine? How will physiatrists fit in? PM R: 7(4 Suppl):S76–S80
Sihvonen R, Paavola M, Malmivaava A, Itala A, Joukainen A, Nurmi H et al (2013) Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med 369:2515–2524
Solbakk J, Zoloth L (2011) The tragedy of translation: the case of “first use” in human embryonic stem cell research. Cell Stem Cell 8(5):479–481
StemCells (2013) StemCells, Inc. announces results of long-term follow-up study in Batten Disease. http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle&id=1866312. Accessed 13 Oct 2016
Sugarman J (2010) Reflections on governance models for the clinical translation of stem cells. J Law Med Ethics 38(2):251–256
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Tauer C, Master Z, Campo-Engelstein L (2014) Embryo research. In: Jennings B (ed) Bioethics, 4th edn. Cengage Learning, Farmington Hills, MI, pp 923–935
Thompson D (1993) Understanding financial conflicts of interest. N Engl J Med 329:573–576
Acknowledgement
Preparation of this Article is Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (Award No. UL1TR000454).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Banja, J.D. (2017). Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions. In: Pham, P., Rosemann, A. (eds) Safety, Ethics and Regulations. Stem Cells in Clinical Applications. Springer, Cham. https://doi.org/10.1007/978-3-319-59165-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-59165-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59164-3
Online ISBN: 978-3-319-59165-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)